No insider purchase over the last 90 days. The latest was filed 18 Dec 2024.
Every trade that managers of 3D Systems Corp disclose to SEC (Form 4) is tracked on this page. The company sits in the Technology sector. 16 insiders have disclosed 46 filings since 18 October 2025.
All open-market trades in the period are sales: 3 sales worth €548k, by 2 insiders, with no purchase on record. One trade stands out by size: a sale of €322k from Graves Jeffrey A, disclosed on 21 August 2026, or 0.062% of market capitalisation.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (5,458 companies, median 22 filings), a count of 46 filings is above the norm. Since 2016, the database holds 8 purchases and 34 sales by insiders of the company. The 10-K for the year ended 31 December 2025 shows 386.9 m USD of revenue and 29.9 m USD of net income.
In the same sector, recent insider purchases at Gitlab Inc. and Baozun Inc. also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 282 declarations
3D Systems Corp. (ticker DDD) is a U.S.-based technology company listed on the NYSE in the United States and widely regarded as one of the pioneers of 3D printing and additive manufacturing. The company traces its origins to the work of Chuck Hull, the inventor of stereolithography, and was built into a commercial platform from its headquarters in Rock Hill, South Carolina. Over time, 3D Systems has developed an application-led business model spanning hardware, materials, software, and related services, with a focus on high-value manufacturing and healthcare use cases.
Today, the company’s operations are organized around two core segments: Healthcare Solutions and Industrial Solutions. Healthcare Solutions includes dental, medical device, personalized health services, and regenerative medicine activities, while Industrial Solutions covers aerospace, defense, transportation, and general manufacturing applications. This structure gives the company a broader exposure than a pure equipment vendor, combining recurring consumables and services with system sales. At the same time, customer capital spending cycles remain an important variable for revenue and profitability.
3D Systems occupies a historically important position in the additive manufacturing industry. It competes with other established players such as Stratasys, EOS, Materialise, and a range of specialized industrial printing companies. Its competitive advantage comes from being an early mover, maintaining a sizable installed base, and offering an integrated stack of printers, materials, and software. Key product families include stereolithography (SLA) systems, polymer and metal printing solutions, proprietary materials, and workflow software designed to help customers move from digital design to production.
Recent company updates show a continued strategic emphasis on the most attractive end markets. In 2025, 3D Systems announced the full commercial release of its FDA-cleared NextDent Jetted Denture Solution for the U.S. market, reinforcing its digital dentistry portfolio. The company also introduced next-generation SLA solutions and highlighted efficiency gains from its cost-reduction programs. In its first-quarter 2026 results, 3D Systems said performance improved in Healthcare, Dental, Med Tech, and Aerospace & Defense. For investors, DDD remains a cyclical growth-tech name with long-term exposure to industrial digitization, medical innovation, and the broader adoption of additive manufacturing across mission-critical applications.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 386.9 m USD | 29.9 m USD | 0.19 USD | n.d. | 10-K |
| Dec 2024 | 440.1 m USD | -255.6 m USD | -1.94 USD | 0.00 USD | 10-K |
| Dec 2023 | 488.1 m USD | -362.7 m USD | -2.79 USD | 0.00 USD | 10-K |
| Dec 2022 | 538.0 m USD | -122.7 m USD | -0.96 USD | 0.00 USD | 10-K |
| Dec 2021 | 615.6 m USD | 322.1 m USD | 2.55 USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.